Peter Anevski - 17 Oct 2022 Form 4 Insider Report for Progyny, Inc. (PGNY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
19 Oct 2022, 16:20:00 UTC
Prior SEC filing
17 Oct 2022
Next SEC filing
24 Oct 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark Livingston, Attorney-in-Fact

Key filing fact

Peter Anevski filed Form 4 for Progyny, Inc. (PGNY) on 19 Oct 2022.

Key facts

  • This page summarizes Peter Anevski's Form 4 filing for Progyny, Inc. (PGNY).
  • 11 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 19 Oct 2022, 16:20.

Change

  • Previous filing in this sequence was filed on 17 Oct 2022.
  • Current net transaction value: -$838,784.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PGNY transaction

Common Stock

Options Exercise

Transaction value
$1,580
Shares
+400
Change %
+0.16%
Price
$3.95*
Shares after
250,845
Date
17 Oct 2022
Ownership
Direct
PGNY transaction

Common Stock

Sale

Transaction value
$15,732
Shares
-400
Change %
-0.16%
Price
$39.33
Shares after
250,445
Date
17 Oct 2022
Ownership
Direct
Footnotes
F1
PGNY transaction

Common Stock

Sale

Transaction value
$3,933
Shares
-100
Change %
-0.05%
Price
$39.33
Shares after
190,637
Date
17 Oct 2022
Ownership
See footnote
Footnotes
F1, F2
PGNY transaction

Common Stock

Options Exercise

Transaction value
$71,100
Shares
+18,000
Change %
+7.2%
Price
$3.95*
Shares after
268,445
Date
18 Oct 2022
Ownership
Direct
PGNY transaction

Common Stock

Sale

Transaction value
$690,798
Shares
-17,440
Change %
-6.5%
Price
$39.61
Shares after
251,005
Date
18 Oct 2022
Ownership
Direct
Footnotes
F1, F3
PGNY transaction

Common Stock

Sale

Transaction value
$22,641
Shares
-560
Change %
-0.22%
Price
$40.43
Shares after
250,445
Date
18 Oct 2022
Ownership
Direct
Footnotes
F1, F4
PGNY transaction

Common Stock

Sale

Transaction value
$172,700
Shares
-4,360
Change %
-2.3%
Price
$39.61
Shares after
186,277
Date
18 Oct 2022
Ownership
See footnote
Footnotes
F1, F2, F3
PGNY transaction

Common Stock

Sale

Transaction value
$5,660
Shares
-140
Change %
-0.08%
Price
$40.43
Shares after
186,137
Date
18 Oct 2022
Ownership
See footnote
Footnotes
F1, F2, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PGNY transaction Derivative

Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-400
Change %
-0.03%
Price
$0.000000
Shares after
1,491,713
Date
17 Oct 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
400
Exercise price
$3.95
Footnotes
F5
PGNY transaction Derivative

Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-18,000
Change %
-1.2%
Price
$0.000000
Shares after
1,473,713
Date
18 Oct 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
18,000
Exercise price
$3.95
Footnotes
F5
PGNY transaction Derivative

Option (Right to Buy)

Award

Transaction value
$0
Shares
+800,000
Change %
Price
$0.000000
Shares after
800,000
Date
18 Oct 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
800,000
Exercise price
$39.39
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022.

Footnote F2

The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.37 to $40.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.40 to $40.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F5

One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Footnote F6

One-fourth (1/4th) of the shares subject to the option will vest October 17, 2023 and the remainder of the shares will vest in equal quarterly installments thereafter through October 17, 2026, subject to the Reporting Person continuing to provide service through each such date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .